Peer-influenced content. Sources you trust. No registration required. This is HCN.
Addiction Professional
The alarming findings on nitazenes’ impact on cardiac arrest rates and naloxone dosage requirements demand your attention; further details could change how we approach opioid overdose treatments.
Emergency Medicine September 6th 2023
American Journal of Endocannabinoid Medicine (AJEM)
Learn more about how the HHS’s recommendation to reschedule marijuana could revolutionize research and impact your practice, offering more comprehensive treatment options for patients.
Family Medicine/General Practice September 6th 2023
Psych Congress Network
Understanding the neural mechanisms behind emotional control in anxious individuals could offer new avenues for therapeutic interventions. Discover how a shift from FPl to dorsolateral prefrontal cortex may impact emotional regulation in anxiety disorders.
Neurology September 6th 2023
The Epoch Times
New research reveals elevated levels of toxic heavy metals in marijuana users, highlighting the need for physicians to consider this when treating patients with conditions that may be impacted by heavy metal exposure.
This longitudinal study offers valuable insights into the complex effects of medical cannabis on quality of life in anxiety patients. Physicians may find the nuanced findings on mental and physical well-being particularly relevant for treatment considerations.
Family Medicine/General Practice August 30th 2023
Mayo Clinic Labs
Discover how Mayo Clinic’s new lab test can enhance your ability to accurately distinguish between new and residual marijuana use, thereby informing better clinical and legal decisions.